[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368859-105":59,"doc-detail-368859-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","from-early-diagnoses-to-new-treatments-for-liver-pancreatic-gastric-and-colorectal-cancers-using-carbon-nanotubes-new-chances-still-underexplored","From Early Diagnoses to New Treatments for Liver, Pancreatic, Gastric, and Colorectal Cancers Using Carbon Nanotubes: New Chances Still Underexplored","","Pancreatic, liver, gastric, colorectal, and rectal cancers are highly lethal, with very low 5-year survival for pancreatic and liver disease and poor outcomes for advanced gastric, colorectal, and rectal stages. Negative prognoses stem from late diagnosis, limited effectiveness of current therapies, recurrence, therapy-induced secondary tumorigenesis, and drug resistance. Nanomaterials have improved anticancer efforts, and carbon nanotubes stand out as versatile platforms for drugs, antibodies, and genes, including photothermal, photodynamic, and targeting strategies, yet research coverage and translational readiness remain limited. An umbrella review compiles case studies and emphasizes safer innovations, toxicological clarification, regulatory barriers, and patent-focused development to accelerate clinical translation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/from-early-diagnoses-to-new-treatments-for-liver-pancreatic-gastric-and-colorectal-cancers-using-carbon-nanotubes-new-chances-still-underexplored/368859/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/from-early-diagnoses-to-new-treatments-for-liver-pancreatic-gastric-and-colorectal-cancers-using-carbon-nanotubes-new-chances-still-underexplored/368859.png","ImageObject",300,407,{"name":92,"@type":93},"Aldword","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are pancreatic, liver, gastric, colorectal, and rectal cancers particularly difficult to treat?","Question",{"text":112,"@type":113},"Their poor prognoses are linked to late diagnosis, limited treatment efficacy, recurrence, therapy-induced secondary tumorigenesis, and drug resistance, leading to very low survival rates in several stages.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role do carbon nanotubes (CNTs) play in cancer diagnosis and therapy?",{"text":117,"@type":113},"CNTs are presented as high-potential nano-systems that can act as vehicles for drugs, antibodies, and genes. They can be used alone or combined with strategies such as photothermal, photodynamic, targeting, gene, immune, and chemotherapy approaches to enhance anticancer effects and reduce toxic outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"What gaps and priorities does the review highlight for future CNT research?",{"text":121,"@type":113},"The review stresses the underexplored nature of studies using CNT-based innovative nanomaterials for these cancers, the need to clarify toxicological aspects and regulatory hurdles, and the importance of developing patent-ready innovations rather than only journal publications to speed translation into clinical practice.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368859,1790438363,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nFrom Early Diagnoses to New Treatments for Liver, Pancreatic, Gastric, and Colorectal Cancers Using Carbon Nanotubes: New Chances Still Underexplored  \nSilvana Alfei 1, *, Caterina Reggio 2 and Guendalina Zuccari 1,2, *  \nAcademic Editors: Arnau Panisello-Roselló and Emma Folch-Puy  \nReceived: 23 August 2025  \nRevised: 13 September 2025  \nAccepted: 17 September 2025  \nPublished: 20 September 2025  \nCitation: Alfei, S.; Reggio, C.; Zuccari, G. From Early Diagnoses to New Treatments for Liver, Pancreatic, Gastric, and Colorectal Cancers Using Carbon Nanotubes: New Chances Still Underexplored. Int. J. Mol. Sci. 2025, 26, 9201. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26189201  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano, 4, 16148 Genoa, Italy  \n2 Laboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, Via G. Gaslini 5, 16147 Genoa, Italy; [caterinareggio@gaslini.org](caterinareggio@gaslini.org)  \n* Correspondence: [alfei@difar.unige.it](alfei@difar.unige.it) (S.A.); [guendalina.zuccari@unige.it](guendalina.zuccari@unige.it) (G.Z.); Tel.: +39-010-355-2296 (S.A.)  \nAbstract  \nPancreatic, liver, gastric, colorectal, and rectal cancers (PC, LC, GC, CRC, and RC) are highly lethal tumours, with a 5-year survival rate of 10.5%(PC) and \u003C20%(LC), and of 5%, 12%, and 13% for IV-stage GC, CRC, and RC, respectively. Currently, PC and LC represent the third leading cause of cancer-related death, while GCs and CRCs account for 4.8 million cancer cases and 4.4 million cancer deaths worldwide. Poor prognoses are mainly due to late diagnosis, limited efficacy of available treatments, tumour recurrence, as well as therapy-induced secondary tumorigenesis and drug resistance. In recent decades, these issues have been afforded using nanomaterials (NMs), with promising results. Carbon nanotubes (CNTs) are nonpareil nano systems, which have demonstrated high potential in both cancer diagnosis and treatment, showing to be excellent vehicles for drugs, antibodies, genes, etc. Used alone or in combination with available therapeutic strategies, such as photothermal, photodynamic, drug targeting, gene, immune, and chemotherapies, CNTshave shown notable results in laboratory settings, enhancing the anticancer effects and reducing toxic outcomes of traditional treatments. Anyway, despite PC, LC, and CRC being three of the five tumours (60%) considered the most perfidious and lethal cancers, studies on the use of these innovative NMs to cure them represent only 37% of those regarding the treatment of the most known tumours. Regarding this scenario of a worrying lack of efficient treatments for highly lethal PC, LC, GC, CRC, and RC, this umbrella review was drawn up to promote filling this gap in studies by reporting the still too limited and often obsolete experimentation on the possible use of CNTs for their diagnosis and therapy. To this end, such case studies have been collected in several informative Tables which are functional for readers, and the studies have been discussed. This study wants to sensitize scientists towards more extensive research to find novel safer applications of CNTs against PC, LC, GC, CRC, and RC, both in terms of early diagnoses and efficient treatments. Such efforts should also focus on clarifying the not yet fully unveiled toxicological aspects and regulatory hurdles, both of which persist around CNTs. Research should also be finalized to produce patents rather than journal articles, thus accelerating the translation of CNTs to clinical practice.  \nKeywords: carbon nanotubes (CNTs); CNT-impro","cbCaihH2zlVEWxCy","https://ap.wps.com/l/cbCaihH2zlVEWxCy","pdf",3575929,47,"English","# Abstract\n# Introduction","[{\"question\":\"Why are pancreatic, liver, gastric, colorectal, and rectal cancers particularly difficult to treat?\",\"answer\":\"Their poor prognoses are linked to late diagnosis, limited treatment efficacy, recurrence, therapy-induced secondary tumorigenesis, and drug resistance, leading to very low survival rates in several stages.\"},{\"question\":\"What role do carbon nanotubes (CNTs) play in cancer diagnosis and therapy?\",\"answer\":\"CNTs are presented as high-potential nano-systems that can act as vehicles for drugs, antibodies, and genes. They can be used alone or combined with strategies such as photothermal, photodynamic, targeting, gene, immune, and chemotherapy approaches to enhance anticancer effects and reduce toxic outcomes.\"},{\"question\":\"What gaps and priorities does the review highlight for future CNT research?\",\"answer\":\"The review stresses the underexplored nature of studies using CNT-based innovative nanomaterials for these cancers, the need to clarify toxicological aspects and regulatory hurdles, and the importance of developing patent-ready innovations rather than only journal publications to speed translation into clinical practice.\"}]","From Early Diagnoses to New Treatments for Liver, Pancreatic, Gastric, and Colorectal Cancers Using Carbon Nanotubes: New Chances Still Underexplored | PDF",1790178952,118,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71f7d9dfd6ae959fadf7420591f0db34.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34ab92c10cfbc5797915601251de2b91.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55938b3d52e75ec711ce2343324e0dbd.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e1119388cb947021e0ab7143358e036.webp",980,1385,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b412fc28bba7098b46c1e665c60bbc1.webp",979,1384]